Unknown

Dataset Information

0

Safety monitoring of COVID-19 vaccines in Japan.


ABSTRACT: The assessment of the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines in actual practice is extremely important, and monitoring efforts are being implemented worldwide. In Japan, a joint council in the Ministry of Health, Labour and Welfare is held every two to three weeks to summarise information on the adverse events following COVID-19 vaccination, with careful assessment of individual case safety reports and comparison with background incidence rates. In 2021, the joint council mainly reviewed anaphylaxis, death, myocarditis/pericarditis, and thrombosis with thrombocytopenia syndrome. These activities resulted in several safety-related regulatory actions, including the revision of vaccine package inserts with warnings about myocarditis/pericarditis. International sharing of vaccine safety information, as well as details of the evaluation systems, is important for international discussion and decision-making on better safety monitoring of COVID-19 vaccines.

SUBMITTER: Yamaguchi T 

PROVIDER: S-EPMC8960038 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8055510 | biostudies-literature
| S-EPMC8426829 | biostudies-literature
| S-EPMC8926428 | biostudies-literature
| S-EPMC9489473 | biostudies-literature
| S-EPMC9726273 | biostudies-literature
| S-EPMC9483089 | biostudies-literature
| S-EPMC9143867 | biostudies-literature
| S-EPMC10974422 | biostudies-literature
| S-EPMC7718775 | biostudies-literature
| S-EPMC8774988 | biostudies-literature